DENTSPLY SIRONA (NASDAQ: XRAY) SHAREHOLDER ALERT: POTENTIAL COMPENSATION CLAIMS: Rosca Scarlato Investor Lawyers Investigating

PHILADELPHIA, May 10, 2023

Dentsply investors who invested in or before June 2021, are concerned about the XRAY stock price performance, and would like to discuss potential claims may contact Alan Rosca at arosca@rscounsel.law, 888-998-0530, or through the Dentsply Sirona Class Action Investigation page.

In 2022, Dentsply, and its former Chief Executive Officer and Chief Financial Officer were sued for allegedly orchestrating a scheme to inflate Dentsply's revenue and earnings by manipulating the Company's accounting for a rebate program, so that senior executives would be eligible for significant cash and stock-based incentive compensation. To facilitate this scheme, the defendants allegedly made numerous false and misleading statements to investors during the class period. Later same year, Dentsply disclosed an internal investigation by the Company that determined that Dentsply's former CEO and CFO "engaged in conduct that was inconsistent with the Company's culture of compliance and Code of Ethics and Business Conduct."

Dentsply Shareholders May Be Able to Pursue Claims for Compensation

Investor rights attorneys Alan Rosca and Paul Scarlato at Rosca Scarlato are evaluating potential claims for compensation and/or other redress on behalf of XRAY shareholders. They have decades of combined experience representing victims of corporate or financial misconduct.

If you are a Dentsply investor who invested in or before June 2021, continue to hold your XRAY shares, and would like to learn more about potential options for compensation and/or other redress, you may contact attorneys Rosca and Scarlato for a free evaluation of your potential claims.

The Rosca Scarlato attorneys take cases like this on a contingency fee basis, advance all case expenses, and only get paid for their fees and expenses if and when they are successful, following review by the Court of any fee application.